Edwards Lifesciences Corp (NYSE:EW) currently has a daily average trading volume of 4.69M but it saw 4874412 shares traded in last market. With a market cap of 44.27B USD, the company’s current market price of $75.47 came falling about -0.44 while comparing to the previous closing price of $75.80. In past 52 weeks, the stock remained buoying in the range of price level as high as $95.25 and as low as $58.93.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Piper Sandler which upgraded the stock as “Overweight” in its note to investors issued on April 24, 2025, recommending a price target of $80 for it. Stifel upgraded its recommendation for the stock as a “Buy” from “Hold” on January 30, 2025 while assigning a price target range of $75-$90. Wolfe Research issued its recommendations for the stock as it downgraded the price target for the stock is $60.
Over the week, EW’s stock price is moving -3.06% down while it is 0.90% when we observe its performance for the past one month. Year-to-date it is 1.95% up and over the past year, the stock is showing a downside performance of -14.37%.
Currently, Edwards Lifesciences Corp’s total number of outstanding shares is 586.20M. Company’s return on investment (ROI) stands at 8.22% and return on equity (ROE) at 16.73%. It has a price to earnings ratio (P/E ratio) of 50.42 while having a 27.40 of forward P/E ratio. Stock’s beta reads 1.12. Stock has a price to book (P/B) ratio of 4.37 while price to sale or P/S ratio amounts to 7.99. Its return on asset (ROA) is 12.68% on average.
